NCT06316895Recruiting
The Clinical Outcomes and Prediction of Thermal Ablation for Low-risk Papillary Thyroid Carcinoma
The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Low-risk Papillary Thyroid Carcinoma
Source: ClinicalTrials.gov · Last updated 20 Mar 2026
Brief summary (registry, in English)
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3772 (estimated)
- First submitted
- 16 Feb 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Apr 2027
- Lead sponsor
- Chinese PLA General Hospital
- Diseases
- Thyroid cancer
- NCT number
- NCT06316895
What you commit to
- Study type: Observational
- Planned participants: 3772
- From 1 Apr 2024 to the primary completion date, 1 Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
- history of neck radiation
- history of thyroid surgery
- coagulation disorder
- serious heart, respiratory, liver, or renal failure
Other
- dysfunction of the vocal cord on the opposite side
Who the study is looking for
- patients age between 18 and 80 year old, both sex
- papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
- the largest diameter ≤2.0 cm
- no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, nech and chest CT
- follow-up period ≥12 months,
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Chinese PLA General Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.